Latest Distribution Agreements News

Page 1 of 30
Associate Global Partners lifted funds under management 20% to $1.672 billion in FY2026, supported by $172 million of net inflows and WCM-related capital raisings. Momentum continued into FY2027, although reported FUM had eased to $1.549 billion by 17 November after renewed market volatility.
Claire Turing
Claire Turing
19 Nov 2026
Lark Distilling reported 15.1% FY26 sales growth and entered FY27 debt-free, but shareholders delivered a sharp rebuke on executive pay and director fees. The company now has to turn its new production platform, Signature range and international push into positive operating cash flow.
Victor Sage
Victor Sage
19 Nov 2026
CurveBeam AI has received its first Chinese order for four HiRise weight-bearing CT systems from Weiying/Wego Orthopedics, turning regulatory clearance into an initial commercial foothold. The order value and delivery schedule were not disclosed, while a further A$1 million milestone investment is expected this quarter.
Victor Sage
Victor Sage
19 Nov 2026
Shriro Holdings delivered a sharp FY26 profit increase, but is guiding to lower EBITDA in FY27 as it funds the launch of its Everdure Lagoon BBQ range and absorbs normalised calculator sales. The debt-free group says its balance sheet still gives it room to invest, return capital and pursue acquisitions.
Victor Sage
Victor Sage
18 Nov 2026
Yowie Group has appointed GBA Capital and Boston Global to lead a proposed A$2.5 million placement, with the company’s shares still suspended from ASX trading. The raising is intended to support a shift towards a multi-brand confectionery business and help satisfy the conditions for a possible reinstatement.
Victor Sage
Victor Sage
18 Nov 2026
Australian Vintage says its FY26 turnaround has restored positive free cash flow excluding growth investments, while Poco Vino sales and international expansion gather pace. The wine group is targeting a return to net cash in FY27, but has also withdrawn its 2040 net-zero emissions target.
Victor Sage
Victor Sage
18 Nov 2026
Biome Australia has secured an exclusive mainland China cross-border e-commerce agreement with H&S Global, targeting A$2.0 million in Year 1 purchases from an early 2027 launch. The target is larger than Biome’s entire FY26 international sales, but the company will fund 25% of Year 1 invoiced value in marketing and operational support.
Ada Torres
Ada Torres
9 Nov 2026
BTC Health has expanded its exclusive ExoVasc PEARS distribution rights from Australia into India under a new five-year agreement. The opportunity is potentially significant, but Indian sales remain dependent on CDSCO import approval.
Ada Torres
Ada Torres
6 Nov 2026
Cardinal Health has lifted its fiscal 2027 earnings outlook after a strong opening quarter, with revenue reaching US$67.5 billion and non-GAAP diluted EPS rising 28%. The healthcare distributor also completed a US$500 million share repurchase and advanced several strategic initiatives.
Ada Torres
Ada Torres
5 Nov 2026
WEC Energy Group has established a framework to sell up to US$4 billion of common stock, including through forward transactions. No shares have been sold under the agreement yet, leaving the timing, proceeds and potential dilution unresolved.
Maxwell Dee
Maxwell Dee
5 Nov 2026
TKO delivered a sharp third-quarter earnings lift, powered by UFC rights revenue and FIFA World Cup hospitality, and raised its full-year 2026 targets for the second time. The sports and entertainment group also plans to fund further share buybacks partly with additional debt.
Victor Sage
Victor Sage
5 Nov 2026
Marine Biomedical has secured US FDA 510(k) clearance for PearlBone, giving Orthocell a clearer path into bone regeneration through its 12% strategic stake and distribution rights. The commercial opportunity is advancing, but revenue, launch timing and definitive distribution arrangements remain undisclosed.
Ada Torres
Ada Torres
3 Nov 2026

Browse the archive

Full archive